Acumen Pharmaceuticals (ABOS)
Develops sabirnetug, an investigational antibody for early symptomatic Alzheimer’s disease.
$2.73
After hours+0.08 (+3.20%)
At close$2.65(+2.12%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
in 50 days
EPS estimate
−$0.43
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.62−$0.48−$0.68−$0.44−$0.41−$0.33−$0.45Pending
Estimate−$0.47−$0.56−$0.54−$0.63−$0.50−$0.40−$0.36−$0.43
Surprise−31.9%+14.3%−25.9%+30.2%+18.0%+18.1%−25.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported——————$92.0KPending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.31 | — | — |
| Sep 2027 | −$0.31 | — | — |
| Jun 2027 | −$0.29 | — | — |
| Mar 2027 | −$0.30 | — | — |
| Dec 2026 | −$0.36 | — | — |
| Nov 2026 | −$0.43 | — | — |
| Aug 2026 | −$0.36 | −$0.45 | −25.2% |
| May 2026 | −$0.40 | −$0.33 | +18.1% |
| Mar 2026 | −$0.50 | −$0.41 | +18.0% |
| Nov 2025 | −$0.63 | −$0.44 | +30.2% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.31 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.31 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.29 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.30 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.36 | — | — | $0 | — | — | — |
| Nov 11, 2026 | −$0.43 | — | — | $0 | — | — | — |
| Aug 11, 2026 | −$0.36 | −$0.45 | −25.2% | — | $92.0K | — | +1.6% |
| May 12, 2026 | −$0.40 | −$0.33 | +18.1% | — | — | — | −3.5% |
| Mar 26, 2026 | −$0.50 | −$0.41 | +18.0% | — | — | — | −3.0% |
| Nov 12, 2025 | −$0.63 | −$0.44 | +30.2% | — | — | — | −1.0% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 26, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 27, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 28, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| Jul 2, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |